Assessment of the risk of a decrease in the number of endothelial cells after the CyPass stent implantation, real-life study

• Conditions: H40.1; Corneal scars and opacities; H17; Primary open-angle glaucoma

• Registration Number: DRKS00023580
• Lead Sponsor: Diakonie Klinikum Dietrich Bonhoeffer GmbH

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2020-03-01
• Study Start: 2020-12-08
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 319

Inclusion Criteria

All patients who came to the Clinic for Ophthalmology in Neubrandenburg for a check-up as part of the CyPass recall.

Exclusion Criteria

no

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Determination of the effect of the CyPass stent on the endothelial cell count and the cornea and their correlation with the stent position in the everyday practice of our own patients.

Secondary Outcome Measures

Name	Time	Method
Determination of the proportion of necessary surgical interventions for safety after implantation of the CyPass stent.<br><br>